NPI: 1467806646 · MEMPHIS, TN 38104 · Clinical Medical Laboratory · NPI assigned 04/14/2016
Authorized official HIGHAM, JAY controls 20+ related entities in our dataset. Read more
| Authorized Official | HIGHAM, JAY (CEO) |
| Parent Organization | VCPHCS, LP |
| NPI Enumeration Date | 04/14/2016 |
Other providers sharing the same authorized official: HIGHAM, JAY
| Provider | City | State | Total Paid |
|---|---|---|---|
| BHG XLII, LLC | VIRGINIA BEACH | VA | $26.97M |
| MICHIGAN THERAPEUTIC CONSULTANTS PC | MOUNT PLEASANT | MI | $23.78M |
| VALHALLA PLACE, LLC | WOODBURY | MN | $22.06M |
| PHOENIX HEALTH CENTER LLC | HAGERSTOWN | MD | $21.41M |
| VALHALLA PLACE, LLC | BROOKLYN PARK | MN | $19.08M |
| ALLIANCE CLINIC, LLC | MINNEAPOLIS | MN | $19.04M |
| DRD MANAGEMENT, INC | NEW ORLEANS | LA | $16.90M |
| BHG XLI, LLC | CHESAPEAKE | VA | $16.62M |
| BHG XXVI, LLC | HAZARD | KY | $16.14M |
| CENTER FOR BEHAVIORAL HEALTH KENTUCKY LLC | LOUISVILLE | KY | $13.15M |
| CENTER FOR BEHAVIORAL HEALTH INDIANA LLC | FORT WAYNE | IN | $12.32M |
| VCPHCS XII, LLC | DENVER | CO | $11.54M |
| B TEK, LLC | WOODBURY | MN | $10.26M |
| BHG XLII, LLC | GLEN ALLEN | VA | $10.15M |
| BHG XLII, LLC | NEWPORT NEWS | VA | $9.32M |
| VALHALLA PLACE BRAINERD LLC | BRAINERD | MN | $8.76M |
| DRD MANAGEMENT, INC | KNOXVILLE | TN | $8.55M |
| BHG XXIV, LLC | PAINTSVILLE | KY | $7.40M |
| CENTER FOR BEHAVIORAL HEALTH KENTUCKY LLC | RICHMOND | KY | $7.19M |
| CENTER FOR BEHAVIORAL HEALTH LOUISIANA LLC | SHREVEPORT | LA | $7.05M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 148,423 | $2.69M |
| 2019 | 151,169 | $2.56M |
| 2020 | 144,792 | $2.39M |
| 2021 | 116,166 | $2.14M |
| 2022 | 60,683 | $1.17M |
| 2023 | 46,210 | $1.56M |
| 2024 | 36,565 | $1.52M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 223,371 | 116,278 | $7.15M |
| 80363 | 59,432 | 44,796 | $892K | |
| 80353 | 59,430 | 44,796 | $892K | |
| 80346 | 59,435 | 44,798 | $892K | |
| 80358 | 59,431 | 44,796 | $892K | |
| 80349 | 59,407 | 44,787 | $891K | |
| 80324 | 59,430 | 44,796 | $882K | |
| 80345 | 56,925 | 43,200 | $862K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 3,655 | 1,756 | $306K |
| 82570 | 47,659 | 37,100 | $240K | |
| 80320 | 8,701 | 7,344 | $131K | |
| 80305 | 17 | 14 | $220.76 | |
| 81025 | 18 | 13 | $139.78 | |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 7,097 | 862 | $0.00 |